French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening;Recommandations françaises pour la réalisation et l'interprétation du test de la sueur dans le cadre du dépistage néonatal de la mucoviscidose

Archives de Pediatrie

Volumn 17, Issue 9, 2010, Pages 1349-1358

  Sermet Gaudelus, I ^a   Munck, A ^b   Rota, M ^c   Roussey, M ^d   Feldmann, D ^e  

^a INSERM   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PILOCARPINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANALYTICAL PARAMETERS; ARTICLE; CHLORIDE SWEAT LEVEL; CYSTIC FIBROSIS; DIAGNOSTIC APPROACH ROUTE; FRANCE; IONTOPHORESIS; NEWBORN SCREENING; PRACTICE GUIDELINE; REFERENCE VALUE; SWEAT TEST;

ADMINISTRATION, CUTANEOUS; CHLORIDES; CYSTIC FIBROSIS; HUMANS; INFANT; INFANT, NEWBORN; IONTOPHORESIS; MUSCARINIC AGONISTS; NEONATAL SCREENING; PILOCARPINE; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; SWEAT; SWEATING;

EID: 77956632177     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2010.06.021     Document Type: Article

References (63)

1. Rowe S.M., Miller S., Sorscher E.J. Cystic fibrosis. N Engl J Med 2005, 352:1992-2001.
2. Di Sant'Agnese P.A., Darling R.C., Perera G.A., et al. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease. Pediatrics 1953, 12:549-563.
3. Gonska T., Ip W., Turner D., et al. Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Thorax 2009, 64:932-938.
4. Munck A., Dhondt J.L., Sahler C., et al. Implementation of the French nationwide cystic fibrosis newborn screening program. J Pediatr 2008, 153:228-233.
5. Roussey M., Munck A. Questions soulevées et réponses apportées depuis la généralisation du dépistage néonatal de la mucoviscidose en France. Arch Pediatr 2009, 16:540-542.
6. Coakley J., Scott S., Mackay R., et al. Sweat testing for cystic fibrosis: standards of performance in Australasia. Ann Clin Biochem 2009, 46:332-337.
7. Pratique du test de la sueur en France chez le nourrisson dépisté. État des lieux. Abstract. Fédération des CRCMs 2007.
8. Quinton P.M. Chloride impermeability in cystic fibrosis. Nature 1983, 301:421-422.
9. Anderson M.P., Gregory R.J., Thompson S., et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991, 253:202-205.
10. Rota M., Nguyen-Khoa T., Marchand M. « Test de la sueur » du Collège national de biochimie des hôpitaux. Recommandations pour l'exécution et l'interprétation du test de la sueur. Ann Biol Clin 2008, 66:221-227.
11. Marchand M., Jarreau C., Chauffert M., et al. Le test de la sueur. Ann Biol Clin 1998, 56:215-221.
12. Sermet-Gaudelus I., Bonnefond J.P., NGuyen-Khoa A., et al. Le test de la sueur et son interprétation. Journées Parisiennes de Pédiatrie 1998, 272-281. Ed Flammarion, Paris.
13. LeGrys V.A. Sweat testing for the diagnosis of cystic fibrosis: practical considerations. J Pediatr 1996, 129:892-897.
14. Eng W., LeGrys V.A., Schechter M.S., et al. Sweat testing in preterm and full-term infants less than 6 weeks of age. Pediatr Pulmonol 2005, 40:64-67.
15. Gibson L.E., Cooke R.E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959, 23:545-549.
16. Denning C.R., Huang N.N., Cuasay L.R., et al. Cooperative study comparing three methods of performing sweat tests to diagnose cystic fibrosis. Pediatrics 1980, 66:752-757.
17. Mastella G., Di Cesare G., Borruso A., et al. Reliability of sweat-testing by the Macroduct collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique. Acta Pediatr 2000, 89:933-937.
18. Schales O., Schales S.S. A simple and accurate method for the determination of chloride in biological fluids. J Biol Chem 1941, 140:879-884.
19. Coulometric method for chloride: equipment, reagents, procedure, results and calculation. Sherwood Scientific Ltd. http://www.sherwood.scientific.com/.
20. Nguyen-Khoa T, Borgard JP, Sitruk-Khalfon D, et al. Sweat Test: recommendations for good practice and analytical criteria of the methods used In Cystic Fibrosis: Etiology, Diagnosis and Treatments. Chapter 11. Editor: Paul N. Leatte. Novapublishers 2009.
21. Beauchamp M., Lands L.C. Sweat-testing: a review of current technical requirements. Pediatr Pulmonol 2005, 39:507-511.
22. Hammond K.B., Turcios N.L., Gibson L.E. Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis. J Pediatr 1994, 124:255-260.
23. Heeley M.E., Woolf D.A., Heeley A.F. Indirect measurements of sweat electrolyte concentration in the laboratory diagnosis of cystic fibrosis. Arch Dis Child 2000, 82:420-424.
24. Lezana J.L., Vargas M.H., Karam-Bachara J., et al. Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects. J Cyst Fibros 2003, 2:1-7.
25. van der Merwe D.E., Ubbink J.B., Delport R., et al. Biological variation in sweat chloride conductivity. Ann Clin Biochem 2002, 39:39-43.
26. LeGrys V.A. Sweat analysis proficiency testing for cystic fibrosis. Pediatr Pulmonol 2000, 30:476-480.
27. Rosenstein B.J., Langbaum T.S. Misdiagnosis of cystic fibrosis. Need for continuing follow-up and reevaluation. Clin Pediatr (Phila) 1987, 26:78-82.
28. Desax M.C., Ammann R.A., Hammer J., et al. Nanoduct sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis. Eur J Pediatr 2008, 167:299-304.
29. Besnard M., Munck A., Navarro J. Baby with eczema and abnormal sweat test. Lancet 1996, 348:1737.
30. Jayaraj R., Barton P.V., Newland P., et al. A reference interval for sweat chloride in infants aged between five and six weeks of age. Ann Clin Biochem 2009, 46:73-78.
31. Farrell P.M., Rosenstein B.J., White T.B., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153:S4-S14.
32. Baumer J.H. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. Arch Dis Child 2003, 88:1126-1127.
33. Barben J., Ammann R., Metlagel A., et al. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J Pediatr 2005, 146:183-188.
34. Funk M.J., LeGrys V.A. Testing diagnostic tests: why size matters. J Pediatr 2005, 146:159-162.
35. Losty H.C., Wheatley H., Doull I. The evaluation of a novel conductometric device for the diagnosis of cystic fibrosis. Ann Clin Biochem 2006, 43:375-381.
36. Castellani C., Southern K.W., Brownlee K., et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009, 8:153-173.
37. Comeau A.M., Accurso F.J., White T.B., et al. Guidelines for implementation of cystic fibrosis: newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics 2007, 119:e495-e518.
38. Shwachman H., Leubner H., Catzel P. Mucoviscidosis. Adv Pediatr 1955, 7:249-323.
39. Lenoir G., Nguyen-Khoa T., Simon G., et al. Comment, quand et pourquoi demander un test de la sueur en 1997?. Ann Pediatr 1998, 45:171-177.
40. Farrell P.M., Koscik R.E. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics 1996, 97:524-528.
41. Stewart B., Zabner J., Shuber A., et al. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med 1995, 151:899-903.
42. Feldmann D., Couderc R., Audrezet M.P., et al. CFTR genotypes in patients with normal or borderline sweat chloride levels. Hum Mutat 2003, 22:340.
43. Clinical Laboratory Standards Institute formely National Committee for Clinical Laboratory Standards. Sweat Testing: Sample Collection and Quantitative Analysis: Approved Guideline. NCCLS Document C34-A2. Waye, PA, National Committee for Clinical Laboratory Standards, 2000.
44. Massie J., Gaskin K., Van Asperen P., et al. Sweat testing following newborn screening for cystic fibrosis. Pediatr Pulmonol 2000, 29:452-456.
45. Parad R.B., Comeau A.M., Dorkin H.L., et al. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 2005, 147(Suppl. 3):69-72.
46. Rock M., Makholm L., Lai H., et al. Distribution of sweat chloride values in patients with cystic fibrosis [Abstract]. Pediatr Pulmonol 2003, 25(Suppl.):337.
47. Hardy J.D., Davison S.H., Higgins M.U., et al. Sweat tests in the newborn period. Arch Dis Child 1973, 48:316-318.
48. Massie R.H.J., Gaskin K.J., Van Asperen P.P., et al. The reliability of sweat testing at six weeks following newborn screening for cystic fibrosis in NSW, 1995-1996 [Abstract]. Am J Respir Crit Care Med 1998, 157:126.
49. Sontag M.K., Hammond K.B., Zielenski J., et al. Two tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. J Pediatr 2005, 147(Suppl. 3):83-88.
50. Tacetti G., Festinini F., Braccini G., et al. Sweat testing in newborns positive to neonatal screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 2004, 89:F463-F464.
51. Massie J., Clements B., Australian Paediatric Respiratory Group Diagnosis of cystic fibrosis after newborn screening: the Australasian experience - twenty years and five million babies later: a consensus statement from the Australasian Pediatric Respiratory Group. Pediatr Pulmonol 2005, 39:440-446.
52. Sermet-Gaudelus I., Bonnefont J.P., Nguyen-Khoa A.T., et al. Un test de la sueur normal n'exclut pas le diagnostic de mucoviscidose. Arch Pediatr 2000, 7:594-596.
53. Roussey M., Le Bihannic A., Scotet V., et al. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations. J Inherit Metab Dis 2007, 30:613.
54. Parad R.B., Comeau A.M. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr 2005, 147(Suppl. 3):58-82.
55. Soultan Z.N., Foster M.M., Newman N.B., et al. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening. J Pediatr 2008, 153:857-859.
56. De Boeck K., Wilschanski M., Castellani C., et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006, 61:627-635.
57. Mayell S.J., Munck A., Craig J.V., et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 2009, 8:71-78.
58. Sermet-Gaudelus I., Girodon E., Roussel D., et al. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis. Thorax 2010, 65:539-544.
59. Green A., Kirk J., on behalf of the Guidelines Development Group Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Ann Clin Biochem 2007, 44:25-34.
60. LeGrys V.A., Yankaskas J.R., Quittell L.M., et al. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007, 151:85-89.
61. Tluczek A., Koscik R.L., Farrell P.M., et al. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat test appointment. Pediatrics 2005, 115:1692-1703.
62. Dillard J.P., Tluczek A. Information flow after a positive newborn screening for cystic fibrosis. J Pediatr 2005, 147(Suppl. 3):94-97.
63. Beucher J., Leray E., Deneuville E., et al. Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up. J Pediatr 2010, 156:771-776.